The global pharmaceutical company will build a fill and finishing manufacturing site, creating more than 1,000 jobs.
On Wednesday, the FDA issued a Complete Response Letter (CRL) related to Novo Nordisk A/S’s (NYSE:NVO) Biologics License ...
Wegovy presents an urgent challenge to the sustainability of Medicare and Medicaid, whose budgetary outlook under the status ...
Industry executive Kåre Schultz said that Hims has a “long future” in selling so-called compounded versions of weight-loss ...
(Reuters) -The U.S. Food and Drug Administration has declined to approve Novo Nordisk's weekly insulin in patients with ...
Senator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk can be convinced to cut the U.S. prices of its ...
Novo Nordisk, the maker of weight-loss drug Wegovy, has bought a site in Denmark's third largest city Odense and begun ...
The next wave of obesity drugs could help people lose even more weight—and make some pharma companies a fortune.
Construction is set to begin on a multibillion-dollar battery plant in Mississippi, following what the governor described as ...
The first large, head-to-head comparison between next-generation weight loss drugs finds a clear advantage to one.
Esteve Pharmaceuticals has announced a substantial investment of €100 million ($108 million) to build a new manufacturing ...
It comes as Elon Musk’s car maker is pushing back the big-reveal of its so-called Robotaxis from August to October, according ...